期刊文献+

复方黄黛片在健康志愿者体内的药代动力学研究 被引量:7

Study on pharmacokinetics of the Compound Realgar Natural Indigo Tablets in healthy volunteers
下载PDF
导出
摘要 目的 研究复方黄黛片中砷在健康志愿者体内的药代动力学行为。方法 用ICP -MS测定健康志愿者血中砷的浓度 ,用 3P97处理药动学数据 ,SPSS进行统计分析。结果和结论 健康志愿者药动学参数分别为A =0 .30 6 0± 0 .0 90 9mg·L-1,Ke=0 .0 74 9± 0 .0 12 5 1/h ,Ka =0 .2 199± 0 .0 3471/h ,TLag  =0 .0 72 4± 0 .0 6 2 1h ,T1/ 2  (Ka) =3.2 0 70± 0 .5 2 6 0h ,T1/ 2  (Ke) =9.2 6 6 2± 1.344 4h ,Tpeak  =7.4 4 99± 0 .3184h ,Cmax  =0 .10 75± 0 .0 0 31mg·L-1,AUC =2 .5 5 0 8± 0 .15 2 8mg·L·h-1,CL/F(s) =195 9.1970± 110 .182 2L·h-1,V/F(c) =2 6 2 35 .376 0± 2 731.4 15 8L。单剂量口服复方黄黛片后 。 Aim To study pharmacokinetics of As in the Compound Realgar Natural Indigo Tablets(CRNIT) in healthy volunteers.Methods The As concentrations in serum of healthy volunteers were monitored by ICP-MS,the pharmacokinetic data were processed with 3P97 software and statistics was performed with SPSS software.Results and Conclusion The pharmacokinetic parameters were: A=0.3060±0.0909mg·L -1 ,Ke=0.074 9±0.012 51/h,Ka=0.219 9±0.034 71/h,T Lag =0.072 4±0.062 1h,T 1/2 (Ka)=3.207 0±0.526 0h,T 1/2 (Ke)=9.266 2±1.344 4h,T peak =7.449 9±0.318 4h,C max =0.1075±0.003 1mg·L -1 ,AUC=2.550 8±0.152 8mg·L·h -1 ,CL/F(s)=1 959.1 970±110.1 822L·h -1 ,V/F(c)=26 235.376 0±2 731.415 8L.72hours data obtained from a single oral administration of CRNIT revealed that the elemination model of As was in accordance with first order kinetics.
出处 《解放军药学学报》 CAS 2002年第5期265-267,共3页 Pharmaceutical Journal of Chinese People's Liberation Army
基金 全军"十.五"课题 No.0 1MA0 0 6
关键词 复方黄黛片 健康志愿者 药代动力学 The Compound Realgar Natural Indigo Tablets Pharmacokinetic As Realgar
  • 相关文献

参考文献5

二级参考文献35

  • 1黄世林,郭爱霞,向阳,王晓波,林慧娴,富丽.复方青黛片为主治疗急性早幼粒细胞白血病的临床研究[J].中华血液学杂志,1995,16(1):26-28. 被引量:185
  • 2[1]Akao Y.Leuk Lymphoma,2000;37(1-2):53
  • 3[2]Zhu XH et al.J Natl Cancer Znst,1999; 91:772
  • 4[3]Wallace DC et al.Nature,1999; 283:1482
  • 5[4]Kroemer GN et al Immunol Today,1997;18:44
  • 6[5]Larochette N et al.Exper CellRes,1999;249,413
  • 7[6]Jing Yongkui et al.Blood,1999,94(6):2102
  • 8[7]Kroemer GN et al.Immunol Today,1997;18:44
  • 9[8]Tewari M et al.Cell,1995; 81:1
  • 10[9]Xu L et al.Cell,1998;94:481

共引文献298

同被引文献72

引证文献7

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部